Jean Coutu Group (PJC) (A)

PJC.A-T

Analysis and Opinions about PJC.A-T

Signal
Opinion
Expert
SELL STRENGTH
SELL STRENGTH
April 27, 2017

He does not hold because of valuation and that the sector is one that he does not need to be in. If you are sitting on gains, there is nothing wrong with taking them. It may go up because of share buybacks, however.

Show full opinionHide full opinion

He does not hold because of valuation and that the sector is one that he does not need to be in. If you are sitting on gains, there is nothing wrong with taking them. It may go up because of share buybacks, however.

BUY
BUY
August 19, 2016

Operates pharmacies primarily in Québec. He likes the space and it does meet his criteria. Their cash ROE is just shy of 30%, and their cash ROE/PE metric is about 2.67. Based on those metrics, this would be a good one to own.

Show full opinionHide full opinion

Operates pharmacies primarily in Québec. He likes the space and it does meet his criteria. Their cash ROE is just shy of 30%, and their cash ROE/PE metric is about 2.67. Based on those metrics, this would be a good one to own.

DON'T BUY
DON'T BUY
March 15, 2016

Because of the Québec base and lack of growth, he wouldn’t go to this.

Show full opinionHide full opinion

Because of the Québec base and lack of growth, he wouldn’t go to this.

COMMENT
COMMENT
January 19, 2016

In retail, he would be looking at off-price retail or convenience. Alimentation Couch-Tard (ATD.B-T) is one. Jean Coutu is down about 10%-11% from its highs and is underperforming the group. Likes the consumer, but wants to own one that has a bit of a tailwind.

Show full opinionHide full opinion

In retail, he would be looking at off-price retail or convenience. Alimentation Couch-Tard (ATD.B-T) is one. Jean Coutu is down about 10%-11% from its highs and is underperforming the group. Likes the consumer, but wants to own one that has a bit of a tailwind.

DON'T BUY
DON'T BUY
December 21, 2015

He does not know the seasonality on this one. The chart is not so good. The stock is in a downward trend and may be trying to find support above $18. It is underperforming the market, below the 20 day moving average, and the momentum indicators are on the downside. There is insufficient reason to buy at these levels. Watch it to see if it bottoms.

Show full opinionHide full opinion

He does not know the seasonality on this one. The chart is not so good. The stock is in a downward trend and may be trying to find support above $18. It is underperforming the market, below the 20 day moving average, and the momentum indicators are on the downside. There is insufficient reason to buy at these levels. Watch it to see if it bottoms.

COMMENT
COMMENT
December 4, 2015

Governments are getting really difficult to deal with if you are a pharmacy. This is a good space because healthcare is a growing area, but there are these little headwinds that can give you pause.

Show full opinionHide full opinion

Governments are getting really difficult to deal with if you are a pharmacy. This is a good space because healthcare is a growing area, but there are these little headwinds that can give you pause.

COMMENT
COMMENT
September 4, 2015

The seasonality on this tends to positive in the summer. The stock tends to peak out around the middle of September, so we are getting close to the end of a period of seasonal strength. Technically the trend is down, but seems to be trying to form a base. Trading below its 20 day moving average which is not so good. Short-term momentum indicators are slightly positive. The time to take profits is probably from the middle to the end of September.

Show full opinionHide full opinion

The seasonality on this tends to positive in the summer. The stock tends to peak out around the middle of September, so we are getting close to the end of a period of seasonal strength. Technically the trend is down, but seems to be trying to form a base. Trading below its 20 day moving average which is not so good. Short-term momentum indicators are slightly positive. The time to take profits is probably from the middle to the end of September.

WATCH
WATCH
August 24, 2015

In the downturn this stock most definitely took out its past lows. Had been making a higher lows and higher highs and the last low of around $24 definitely broke. It may be starting to put in a base, but he would like to see it bounce around a bit and find support at around $19 before buying.

Show full opinionHide full opinion

In the downturn this stock most definitely took out its past lows. Had been making a higher lows and higher highs and the last low of around $24 definitely broke. It may be starting to put in a base, but he would like to see it bounce around a bit and find support at around $19 before buying.

WATCH
WATCH
August 17, 2015

There was some news recently on prescriptions in Quebec, similar to Shoppers a couple of years ago. He likes the pharmacy business, however.

Show full opinionHide full opinion

There was some news recently on prescriptions in Quebec, similar to Shoppers a couple of years ago. He likes the pharmacy business, however.

BUY
BUY
August 14, 2015

This has been under pressure because of declining generic drug prices. Pays a decent dividend and, on a valuation basis, this is a good entry point. Likes their franchise model, which means their CapX is much lower than if they were corporately owned. About 95% of the stores are franchised, so there is a reoccurring revenue stream with not a lot of capital tied up.

Show full opinionHide full opinion

This has been under pressure because of declining generic drug prices. Pays a decent dividend and, on a valuation basis, this is a good entry point. Likes their franchise model, which means their CapX is much lower than if they were corporately owned. About 95% of the stores are franchised, so there is a reoccurring revenue stream with not a lot of capital tied up.

COMMENT
COMMENT
May 12, 2015

Kind of a Shoppers Drug Mart of Québec, and has a dominant position there. Stumbled very badly a few years ago making US acquisitions, but are now doing better. Has pretty much has recovered from its woes of the past. This is worth a look.

Show full opinionHide full opinion

Kind of a Shoppers Drug Mart of Québec, and has a dominant position there. Stumbled very badly a few years ago making US acquisitions, but are now doing better. Has pretty much has recovered from its woes of the past. This is worth a look.

COMMENT
COMMENT
May 8, 2015

This stock has done fabulously well. They made all of these acquisitions. The stock has, fairly far, outrun its FMV because of their tremendous momentum with acquisitions. He is not surprised that the stock is setting back. It is historically high and also high against all of his parameters too. It is expensive.

Show full opinionHide full opinion

This stock has done fabulously well. They made all of these acquisitions. The stock has, fairly far, outrun its FMV because of their tremendous momentum with acquisitions. He is not surprised that the stock is setting back. It is historically high and also high against all of his parameters too. It is expensive.

COMMENT
COMMENT
March 18, 2015

Alimenation Couche-Tard (ATD.B-T) or Jean Coutu (PJC.A-T)? He prefers Alimenation Couche-Tard.

Show full opinionHide full opinion

Alimenation Couche-Tard (ATD.B-T) or Jean Coutu (PJC.A-T)? He prefers Alimenation Couche-Tard.

HOLD
HOLD
May 6, 2014

This has done quite well. Pharma business is attractive, but there is some sort of takeover element in this name. A growth story and very well managed. She would wait for a pullback.

Show full opinionHide full opinion

This has done quite well. Pharma business is attractive, but there is some sort of takeover element in this name. A growth story and very well managed. She would wait for a pullback.

BUY WEAKNESS
BUY WEAKNESS
May 5, 2014

Thinks they are driven by money coming out of SC-T when it was acquired. They increased the dividend and this is driving the stock. They are now more shareholder friendly. Doesn’t think it will be sold in our lifetime.

Show full opinionHide full opinion

Thinks they are driven by money coming out of SC-T when it was acquired. They increased the dividend and this is driving the stock. They are now more shareholder friendly. Doesn’t think it will be sold in our lifetime.

Showing 1 to 15 of 204 entries

Jean Coutu Group (PJC) (A)(PJC.A-T) Rating

Ranking : 1 out of 5

Bullish - Buy Signals / Votes : 0

Neutral - Hold Signals / Votes : 0

Bearish - Sell Signals / Votes : 0

Total Signals / Votes : 0

Stockchase rating for Jean Coutu Group (PJC) (A) is calculated according to the stock experts' signals. A high score means experts mostly recommend to buy the stock while a low score means experts mostly recommend to sell the stock.

Jean Coutu Group (PJC) (A)(PJC.A-T) Frequently Asked Questions

What is Jean Coutu Group (PJC) (A) stock symbol?

Jean Coutu Group (PJC) (A) is a OTC stock, trading under the symbol PJC.A-T on the (). It is usually referred to as or PJC.A-T

Is Jean Coutu Group (PJC) (A) a buy or a sell?

In the last year, there was no coverage of Jean Coutu Group (PJC) (A) published on Stockchase.

Is Jean Coutu Group (PJC) (A) a good investment or a top pick?

Jean Coutu Group (PJC) (A) was recommended as a Top Pick by Mohsin Bashir on 2017-04-27. Read the latest stock experts ratings for Jean Coutu Group (PJC) (A).

Why is Jean Coutu Group (PJC) (A) stock dropping?

Earnings reports or recent company news can cause the stock price to drop. Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock.

Is Jean Coutu Group (PJC) (A) worth watching?

0 stock analysts on Stockchase covered Jean Coutu Group (PJC) (A) In the last year. It is a trending stock that is worth watching.

What is Jean Coutu Group (PJC) (A) stock price?

On , Jean Coutu Group (PJC) (A) (PJC.A-T) stock closed at a price of $.